Sedative-hypnotic profile of novel isatin ketals

Pharmacology Biochemistry and Behavior

Volumn 86, Issue 4, 2007, Pages 678-685

  Zapata Sudo, Gisele ^a   Pontes, Luana B ^a   Gabriel, Daniele ^a   Mendes, Thaiana C F ^a   Ribeiro, Núbia M ^a   Pinto, Angelo C ^a   Trachez, Margarete M ^b   Sudo, Roberto T ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

Author keywords

Anesthesia; Derivative; Hypnosis; Isatin; Locomotor activity; Sedation

Indexed keywords

1,3 DIOXOLANE DERIVATIVE; 5' CHLOROSPIRO [1,3 DIOXOLANE 2,3' INDOLIN] 2 ONE; ACETAL; DIOXANE DERIVATIVE; ISATIN DERIVATIVE; PENTOBARBITAL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE MONITORING; BREATHING RATE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; DRUG STRUCTURE; HEART RATE; HYPNOSIS; LOCOMOTION; MALE; MASS SPECTROMETRY; MOLECULAR WEIGHT; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; OPEN FIELD TEST; PRIORITY JOURNAL; RAT; SEDATION; SLEEP TIME;

ANIMALS; DRUG EVALUATION, PRECLINICAL; HYPNOTICS AND SEDATIVES; ISATIN; MALE; MICE; MOLECULAR STRUCTURE; MOTOR ACTIVITY; PENTOBARBITAL; RATS; RATS, WISTAR; SLEEP; STRUCTURE-ACTIVITY RELATIONSHIP;

RATTUS NORVEGICUS;

EID: 34249671744     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2007.02.013     Document Type: Article

References (43)

1. Abel E.L. Behavioral effects of isatin on open field activity and immobility in the forced swim test in rats. Physiol Behav 57 (1995) 611-613
2. Bhattacharya S.K., and Acharya S.B. Further investigations on the anxiogenic effects of isatin. Biog Amines 9 (1993) 453-463
3. Bhattacharya S.K., and Chakrabarti A. Dose-related proconvulsant and anticonvulsant activity of isatin, a putative biological factor, in rats. Indian J Exp Biol 36 (1998) 118-121
4. Bhattacharya S.K., Clow A., Przyborowska A., Halket J., Glover V., and Sandler M. Effect of aromatic amino acids, pentylenetetrazole and yohimbine on isatin and tribulin activity in rat brain. Neurosci Lett 132 (1991) 44-46
5. Bhattacharya S.K., Chakrabarti A., Sandler M., and Glover V. Anxiolytic activity of intraventricularly administered atrial natriuretic peptide in the rat. Neuropsychopharmacology 15 (1996) 199-206
6. Cane A., Tournaire M.C., Barritault D., and Crumeyrolle-Arias M. The endogenous oxindoles 5-hydroxyoxindole and isatin are antiproliferative and proapoptotic. Biochem Biophys Res Commun 276 (2000) 379-384
7. Chiyanzu I., Hansell E., Gut J., Rosenthal P.J., Mckerrow J.H., and Chibale K. Synthesis and evaluations of isatins and thiosemicarbazone derivatives against cruzain, falcipain-2 and rhodesain. Bioorg Med Chem 13 (2003) 3527-3530
8. Chocholova L., and Kolinova M. Effect of isatin (2,3-dioxoindoline) on audiogenic seizures in rats and its relationship to electrographic and behavioural phenomena. Physiol Bohemoslov 28 (1979) 495-502
9. 3H]isatin in rat brain. J Neurochem 84 (2003) 618-620
10. Crumeyrolle-Arias M., Tournaire M.C., Cane A., Launay J.M., Barritault D., and Medvedev A. Inhibition of brain mitochondrial monoamine oxidases by the endogenous compound 5-hydroxyoxindole. Biochem Pharmacol 67 (2004) 977-979
11. Di Fabio R., Capelli A.M., Conti N., Cugola A., Donati D., Feriani A., et al. Substituted indole-2-carboxylates as in vivo potent antagonists acting at the strychnine-insensitive glycine binding site. J Med Chem 40 (1997) 841-850
12. Evanno Y, Dubois L, Sevrin M, Marguet F, Proissant J, Bartsch R, Gille C. 4-Oxo-3,5-dihydro-4H-pyridazano-4,5-b-indole-1-acetamide Derivatives, Their Preparation and their Application in Therapy as GABA Agonists, Fr. PAT. 9,906,406, 11 Feb 1999. Chemical Abstracts 130 168385f. 1999.
13. Geronikaki A., Babaev E., Dearden J., Dehaen W., Filimonov D., Galaeva I., et al. Design, synthesis, computational and biological evaluation of new anxiolytics. Bioorg Med Chem 12 (2004) 6559-6568
14. Glover V., Halket J.M., Watkins P.J., Clow A., Goodwin B.L., and Sandler M. Isatin: identity with the purified endogenous monoamine oxidase inhibitor tribulin. J Neurochem 5 (1988) 656-659
15. Glover V., Medvedev A.E., and Sandler M. Isatin is a potent endogenous antagonist of guanylate cyclase-coupled atrial natriuretic peptide receptors. Life Sci 57 (1995) 2073-2079
16. Halket J.M., Watkins P.J., Przyborowska A., Goodwin B.L., Clow A., Glover V., et al. Isatin (indole-2,3-dione) in urine and tissues. Detection and determination by gas chromatography-mass spectrometry. J Chromatogr 562 (1991) 279-287
17. Hamaue N. Pharmacological role of isatin, an endogenous MAO inhibitor. Yakugaku Zasshi 120 (2000) 352-362
18. Hamaue N., Yamazaki N., Minami M., Endo T., Hirahuji M., Monma Y., et al. Determination of isatin, an endogenous monoamine oxidase inhibitor, in urine and tissues of rats by HPLC. Gen Pharmacol 30 (1998) 387-391
19. Hamaue N., Minami M., Terado M., Hirafuji M., Endo T., Machida M., et al. Comparative study of the effects of isatin, an endogenous MAO-inhibitor, and selegiline on bradykinesia and dopamine levels in a rat model of Parkinson's disease induced by the Japanese encephalitis virus. Neurotoxicology 25 (2004) 205-213
20. Igosheva N., Matta S., and Glover V. Effect of acute stress and gender on isatin in rat tissues and serum. Physiol Behav 80 (2004) 665-668
21. Langley M.S., and Heel R.C. Propofol: a review of its pharmacodynamic and pharmacokinetic properties and use as an intravenous anaesthesia. Drugs 35 (1998) 334-372
22. Medvedev A.E., and Glover V. Tribulin and endogenous MAO-inhibitory regulation in vivo. Neurotoxicology 25 (2004) 185-192
23. Medvedev A.E., Goodwin B., Clow A., Halket J., Glover V., and Sandler M. Inhibitory potency of some isatin analogues on human monoamine oxidase A and B. Biochem Pharmacol 44 (1992) 590-592
24. Medvedev A.E., Clow A., Sandler M., and Glover V. Isatin: a link between natriuretic peptides and monoamines?. Biochem Pharmacol 52 (1996) 385-391
25. Medvedev A., Goodwin B.L., Sandler M., and Glover V. Efficacy of isatin analogues as antagonists of rat brain and heart atrial natriuretic peptide receptors coupled to particulate guanylyl cyclase. Biochem Pharmacol 57 (1999) 913-915
26. Medvedev A.E., Bussygyna O., Pyatakova N., Glover V., and Severina I. Effect of isatin on nitric oxide-stimulated soluble guanylate cyclase from human platelets. Biochem Pharmacol 63 (2002) 763-766
27. Mora S., Diaz-Veliz G., Lungenstrass H., García-González M., Coto-Morales T., Poletti C., et al. Central nervous system activity of the hydroalcoholic extract of Casimiroa edulis in rats and mice. J Ethnopharmacol 97 (2005) 191-197
28. Morley J.E., Farr S.A., and Flood J.F. Isatin inhibits food intake in mice. Eur J Pharmacol 305 (1996) 23-29
29. Orser B.A., Pennefather P.S., and Macdonald J.F. Multiple mechanisms of ketamine blockade on N-methyl-d-aspartate receptors. Anesthesiology 86 (1997) 903-917
30. Pandeya S.N., Sriram D., Nath G., and DeClercq E. Synthesis, antibacterial, antifungal and anti-HIV activities of Schiff and Mannich bases derived from isatin derivatives and N-[4-(49-chlorophenyl)thiazol-2-yl] thiosemicarbazide. Eur J Pharm Sci 9 (1999) 25-31
31. Pandeya S.N., Smitha S., and Stables J.P. Anticonvulsant and sedative-hypnotic activities of N-substituted isatin semicarbazones. Arch Pharm 335 (2002) 129-134
32. Pandeya S.N., Smitha S., Jyoti M., and Sridhar S.K. Biological activities of isatin and its derivatives. Acta Pharm 55 (2005) 27-46
33. Pataki I., Adamik A., and Telegdy G. Isatin (indole-2,3-dione) inhibits natriuretic peptide-induced hyperthermia in rats. Peptides 21 (2000) 373-377
34. Pataki I., Adamik A., Glover V., Tóth G., and Telegdy G. The effects of isatin (indole-2,3-dione) on pituitary adenylate cyclase-activating polypeptide-induced hyperthermia in rats. BMC Neurosci 3 (2002) 1-4
35. Prut L., and Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 463 (2003) 3-33
36. Rajopadhye M., and Popp F.D. Potential anticonvulsants. synthesis and anticonvulsant activity of spiro[1,3-dioxolane-2,3′-indolin]-2′ones and structural analogues. J Med Chem 31 (1988) 1001-1005
37. Sridhar S.K., and Ramesh A. Synthesis and pharmacological activities of hydrazones, Schiff and Mannich bases of isatin derivatives. Biol Pharm Bull 24 (2001) 1149-1152
38. Sridhar S.K., Pandeya S.N., Stables J.P., and Ramesh A. Anticonvulsant activity of hydrazones, Schiff and Mannich bases of isatin derivatives. Eur J Pharm Sci 16 (2002) 129-132
39. Telegdy G., Adamik A., and Glover V. The action of isatin (2,3-dioxoindole) an endogenous indole on brain natriuretic and C-type natriuretic peptide-induced facilitation of memory consolidation in passive-avoidance learning in rats. Brain Res Bull 53 (2000) 367-370
40. Tozawa Y., Ueki A., Manabe S., and Matsushima K. Stress-induced increase in urinary isatin excretion in rats. Reversal by both dexamethasone and α-methyl-P-tyrosine. Biochem Pharmacol 56 (1998) 1041-1046
41. Wagner J., and Wagner M.L. Non-benzodiazepines for the treatment of insomnia. Sleep Med Rev 4 (2000) 551-581
42. Watkins P., Clow A., Glover V., Halket J., Przyborowska A., and Sandler M. Isatin, regional distribution in rat brain and tissues. Neurochem Int 17 (1990) 321-323
43. Zhao X., and Meng F. Substituent effect of halogen (F, Cl and Br) on uracil tetrad: a theoretical study. Theochem 770 (2006) 157-162